EFFECTS OF INTERFERON-GAMMA ON THE ANTIBODY-RESPONSE TO PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE IN MICE

被引:3
作者
TAYLOR, CE
BAKER, PJ
HRABA, T
STASHAK, P
FAUNTLEROY, MB
机构
[1] Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Twinbrook II Research Facility, Rockville, Maryland
关键词
D O I
10.1016/S0171-2985(11)80411-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Different strains of mice were examined for the capacity to produce an Ig subclass-specific antibody response to purified Pseudomonas aeruginosa lipopolysaccharide (PALPS). With the exception of the AKR strain, the predominant isotype for most of the strains tested was IgG3 whereas the least frequent isotype expressed was either IgG2b or IgG1. AKR mice were unique in that the predominant isotype produced was IgG2a, rather than IgG3; however, the administration of anti-interferon gamma antibody, at the time of immunization with PALPS caused a substantial decrease in the IgG2a antibody response. Selected B10 congenic strains were used to assess the relationship between the antibody responses and the major histocompatibility complex (MHC) genes. Here, the isotype-patterns for the antibody responses were essentially the same regardless of the MHC haplotype. Interestingly, an increase in IgG2a, with a concomitant decrease in IgM and IgG1 antibody was noted when C3H mice were given interferon gamma at the time of immunization. These studies indicate that, in general, the antibody response to PALPS consists of IgG3 antibody as the predominant isotype, and that the antibody response can be modified by interferon gamma.
引用
收藏
页码:106 / 120
页数:15
相关论文
共 49 条
[31]   PHARMACODYNAMIC AND PROTECTIVE PROPERTIES OF A MURINE LIPOPOLYSACCHARIDE-SPECIFIC MONOCLONAL-ANTIBODY IN EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PNEUMONIA IN MICE [J].
OISHI, K ;
SONODA, F ;
MIWA, H ;
TANAKA, H ;
WATANABE, K ;
MATSUMOTO, K ;
POLLACK, M .
MICROBIOLOGY AND IMMUNOLOGY, 1991, 35 (12) :1131-1141
[32]   SYNTHESIS OF TWO CLASSES OF ANTIBODY, GAMMA-M AND GAMMA-G OR GAMMA-M AND GAMMA-A, BY IDENTICAL CELLS - AMPLIFICATION OF THE ANTIBODY-RESPONSE TO PNEUMOCOCCAL POLYSACCHARIDE TYPE-III [J].
PASANEN, VJ ;
ASOFSKY, R ;
BAKER, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (05) :1227-1237
[33]  
PATERSON JD, 1992, IMMUNOLOGY, V75, P652
[34]   IMMUNE RESPONSE IN-VITRO .3. DEVELOPMENT OF PRIMARY GAMMAM, GAMMAG, AND GAMMAA PLAQUE-FORMING CELL RESPONSES IN MOUSE SPLEEN CELL CULTURES STIMULATED WITH HETEROLOGOUS ERYTHROCYTES [J].
PIERCE, CW ;
JOHNSON, BM ;
GERSHON, HE ;
ASOFSKY, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 134 (02) :395-&
[35]   INVIVO MANIPULATION OF IGG2A PRODUCTION BY ISOTYPE-SPECIFIC AUTOANTIBODIES [J].
RAJNAVOLGYI, E ;
KURUCZ, I ;
FAZEKAS, G ;
SINTAR, E ;
LASZLO, G ;
GERGELY, J .
MOLECULAR IMMUNOLOGY, 1990, 27 (12) :1241-1248
[36]   INVIVO ISOTYPE REGULATION OF HUMORAL RESPONSES TO DEXTRAN-B1355 IN BALB/C MICE - DOUBLE-CLASS IGG3/IGM PRODUCERS AS A FUNCTION OF AGE [J].
RIVIER, DA ;
TREFTS, PE ;
COOK, KA .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1985, 21 (02) :173-181
[37]   IGG SUBCLASS DISTRIBUTIONS IN ANTI-HAPTEN AND ANTI-POLYSACCHARIDE ANTIBODIES INDUCED BY HAPTENATED POLYSACCHARIDES [J].
SARVAS, HO ;
AALTONEN, LM ;
PETERFY, F ;
SEPPALA, IJT ;
MAKELA, O .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1983, 13 (05) :409-414
[38]   PROTECTION AGAINST INFECTION WITH PSEUDOMONAS-AERUGINOSA BY PASSIVE TRANSFER OF MONOCLONAL-ANTIBODIES TO LIPOPOLYSACCHARIDES AND OUTER-MEMBRANE PROTEINS [J].
SAWADA, S ;
SUZUKI, M ;
KAWAMURA, T ;
FUJINAGA, S ;
MASUHO, Y ;
TOMIBE, K .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (04) :570-576
[39]   SEROTYPE-SPECIFIC SERUM IGG ANTIBODIES TO LIPOPOLYSACCHARIDES OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS - CORRELATION TO DISEASE, SUBCLASS DISTRIBUTION, AND EXPERIMENTAL PROTECTIVE CAPACITY [J].
SCHAAD, UB ;
LANG, AB ;
WEDGWOOD, J ;
BUEHLAMNN, U ;
FUERER, E .
PEDIATRIC RESEARCH, 1990, 27 (05) :508-513
[40]   ASSOCIATION WITH PHAGOCYTIC INHIBITION OF ANTI-PSEUDOMONAS-AERUGINOSA IMMUNOGLOBULIN-G ANTIBODY SUBCLASS LEVELS IN SERUM FROM PATIENTS WITH CYSTIC-FIBROSIS [J].
SHRYOCK, TR ;
MOLLE, JS ;
KLINGER, JD ;
THOMASSEN, MJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 23 (03) :513-516